MOESM10 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
2019-03-04T05:00:00Z (GMT) by
Additional file 10: Figure S8. The KaplanâMeier survival analysis of the signature for LUAD subgroup patients in GSE31210 dataset. Patients of high-risk exhibited poor prognosis in stage I cohort (Pâ<â0.05). There was no association of the risk score with patients of stage II cohort, recurrence cohort, and no recurrence cohort.